Functional significance of the copper transporter ATP7 in peptidergic neurons and endocrine cells in Drosophila melanogaster  by Sellami, Azza et al.
FEBS Letters 586 (2012) 3633–3638journal homepage: www.FEBSLetters .orgFunctional signiﬁcance of the copper transporter ATP7 in peptidergic neurons
and endocrine cells in Drosophila melanogaster
Azza Sellami a, Christian Wegener b,1, Jan A. Veenstra a,⇑
aUniversité de Bordeaux, INCIA UMR 5287 CNRS, 33405 Talence, France
bDepartment of Animal Physiology, Philipps University, Marburg, Germany
a r t i c l e i n f o a b s t r a c tArticle history:
Received 20 March 2011
Revised 3 August 2012
Accepted 6 August 2012
Available online 16 August 2012
Edited by Ned Mantei
Keywords:
AKH
Corazonin
Myosuppressin
SIFamide
RNAi0014-5793/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.febslet.2012.08.009
⇑ Corresponding author. Fax: +33 5400 008 743.
E-mail address: jan.veenstra@u-bordeaux1.fr (J.A.
1 Present address: Neurobiology and Genetics, Theod
University of Würzburg, Würzburg, Germany.The Drosophila ATP7 copper transporter has sequence homology to the human copper transporters
ATP7A and ATP7B, which are defective in Menkes and Wilson disease, respectively. We show here
that in Drosophila ATP7 is expressed by many peptidergic neurons. As C-terminal amidation of neu-
ropeptides depends on the copper-containing enzyme PHM, it seemed likely that in the absence of
ATP7 the activity of PHM might be compromised. Indeed, inhibition of ATP7 expression by RNAi led
to a decrease in mature amidated neuropeptides and the appearance of C-terminally Gly-extended
neuropeptides. The strength of this effect differed from one cell type to another; it was very pro-
nounced for AKH and corazonin, but much less so for SIFamide and myosuppressin. Nevertheless,
down-regulation of ATP7 speciﬁcally in the SIFamide-expressing neurons resulted in male–male
courtship behavior.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Copper is an essential cofactor for a variety of enzymes while at
the same time it is toxic due to its generation of free radicals [1].
Consequently, copper homeostasis is tightly regulated by a number
of speciﬁc membrane transporters, thus allowing uptake of needed
copper and elimination of excess. The P-type ATPase copper trans-
porters ATP7A and ATP7B are regulators of intracellular copper
homeostasis, and are normally located in the trans-Golgi network
where copper is imported and becomes incorporated into cop-
per-dependent enzymes. When intracellular copper concentrations
increase too much, ATP7-A and -B relocate and assure the elimina-
tion of copper from the cell [2]. When one of the copper homeo-
static proteins fails, problems arise. Menkes disease is an often
fatal human disease characterized by cerebral and cerebellar neu-
rodegeneration in which the ATP7A transporter is defective [3],
while patients suffering from Wilson disease have a defective
ATP7B transporter, leading to an accumulation of intracellular cop-
per, particularly in the liver and in the brain [4].
It has been noted that many of the proteins involved in copper
homeostasis are well conserved between mammals and insects [5–
9]. The ATP7A and ATP7B copper transporters are represented by achemical Societies. Published by E
Veenstra).
or-Boveri-Institute, Biocenter,single homolog in Drosophila melanogaster, ATP7 [9]. ATP7 is abun-
dantly expressed in the copper cells in the midgut, acid secreting
cells known to produce metallothionein when copper is abundant
in the food [10], but also in neurons in the central nervous system
[11]. The neuronal distribution suggests that at least some of the
ATP7 expressing cells might produce C-terminally amidated neu-
ropeptides. C-terminal amides in neuropeptides are produced by
the sequential action of two enzymes, a peptidylglycine-a-hydrox-
ylating mono-oxygenase (PHM) and a peptidyl-a-hydroxyglycine
lyase (PAL), which in vertebrates are combined into one bifunc-
tional enzyme called PAM (peptidylglycine a-amidating mono-
oxygenase), but which in Drosophila are encoded by different genes
[12]. Since PHM is dependent on copper [13] the putative expres-
sion of ATP7 in cells producing amidated peptides suggests that its
presence in these cells is necessary to make copper available for
PHM. ATP7 is not the only protein important for copper metabo-
lism. Thus copper is imported into the cell by Ctr1 proteins, en-
coded in Drosophila by three genes, ctr1A, ctr1B and ctr1C [5–9],
and it has previously been suggested that ctr1A is essential for
C-terminal amidation of FMRFamides in the fruit ﬂy [14].
Whereas in mouse models for Menkes disease the ATP7A trans-
porter is non-functional in the entire animal, in Drosophila it is rel-
atively easy to speciﬁcally diminish ATP7 expression in restricted
subsets of neurons using RNAi and the binary UAS-gal4 expression
system [15]. We here describe that RNAi-mediated down
regulation of ATP7 in speciﬁc peptidergic cells leads to a decreaselsevier B.V. All rights reserved.
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strikingly different among different neuropeptidergic cell types.Fig. 1. Colocalization of various neuropeptides in third instar Drosophila melano-
gaster expressing ATP7-gal4-driven LacZ. In each row the picture to the left shows
peptide immunoreactivity in red, the one to the right LacZ immunoreactivity in
green, and a merged image is shown in the middle. (a) corazonin interneurons in
the abdominal neuromeres; (b) sNPF neurons of the hypocerebral ganglion; (c) capa
neuroendocrine cells (Va neurons) in the abdominal neuromeres; (d) AKH endo-
crine cells in the retrocerebral complex; (e) MS neuroendocrine cells in the pars
intercerebralis; (f) MS peripheral neuroendocrine cells in the abdomen; (g)
SIFamide neurons in the pars intercerebralis.2. Materials and methods
2.1. Flies
Flies were raised at 25 C on standard corn meal food in a 12 h
dark/light cycle. Low copper food was prepared by adding 10 lM of
the copper chelator tetrathiomolybdate (Sigma–Aldrich, Saint-
Quentin Fallavier, France) to the food. The AKH-gal4, SIFa-gal4,
Crz-gal4 and MS-gal4 transgenic ﬂies, which express gal4 speciﬁ-
cally in the adipokinetic hormone, SIFamide, corazonin and
myosuppressin-expressing cells, respectively, have been previ-
ously described [16–19]. The UAS-ATP7-RNAi stock w1118;
P{GD3322}v8315 [20] was from the Vienna Drosophila RNAi Cen-
ter and the UAS-ATP7-RNAi stock y1 v1; P{TRiP.JF01534}attP2,
UAS-LacZ and UAS-Dcr2 were from the Bloomington stock center.
The two ATP7-RNAi lines target different parts of the coding se-
quence of the ATP7 gene (Fig. S1). The ATP7-gal4 line [11] was a
kind gift from Dr. Richard Burke (Monash University, Victoria,
Australia).
2.2. Immunohistology and antisera
Rabbit PHM and DIMM antisera were generously provided by
Prof. Paul Taghert (Washington University, St. Louis, USA). Immu-
nohistological procedures and other antisera used are those de-
scribed elsewhere [21].
2.3. Male–male courtship behavior
Flies used in male–male courtship behavior essays were iso-
lated within 6 h of emergence and kept isolated until use. Three-
to-ﬁve day old males to be tested were aspirated into a courtship
chamber of 4 mm by 22 mm diameter with a wild type male. The
percentage of time during a 10 min observation period spent in
courtship behavior (i.e. orientation, following, tapping, wing exten-
sion, licking and (attempted) copulation) was deﬁned as the court-
ship-index [22]. Wing extension was measured separately to
conﬁrm the sexual intensity of the observed behavior.
2.4. Direct MALDI-TOF mass spectrometric peptide proﬁling
The availability of heavy-isotope labeled Drosophila AKH⁄
(pGlu-Leu[13C6,15N]-Thr-Phe-Ser-Pro-Asp-Trp-amide, custom-
made by Iris Biotech, Marktredwitz, Germany, Mw = 982.5 Da, i.e.
7 Da higher than than that of the naturally occuring AKH) and
myosuppressin⁄ (Thr–Asp–Val[d8]–Asp–His–Val–Phe–Leu–Arg–
Phe–amide, custom-made by Biosyntan, Berlin, Germany, Mw =
1255.4 Da, i.e. 8 Da higher than the naturally occuring myosup-
pressin) made it possible to directly semi-quantify the amounts
of AKH and myosuppressin in the the adult CC/hypocerebral gan-
glion complex using direct mass-spectrometric tissue proﬁling as
described previously [23,24]. Such mass spectrometry standards
are not available for SIFamide or corazonin, and for these peptides
we employed the isotopically labeled myosuppressin⁄ as a
standard. We quantiﬁed both the mature amidated peptide and
the substrate for PHM, i.e., the neuropeptide extended with a
C-terminal Gly residue, relative to the isotopically labeled
standards. Retrocerebral complexes of adult ﬂies were punched
out with pulled glass capillaries and spotted onto the MALDI target
for analysis of myosuppressin, corazonin and AKH. For the analysis
of SIFamide brain regions were dissected and analyzed.
Matrix consisted of a saturated solution of recrystallizeda-cyano-4-hydroxycinnamic acid in MeOH/EtOH/H2O 30/30/40%,
and 200 nl was added to each sample with a micropipette. MAL-
DI-TOF mass spectra were acquired in positive ion reﬂectron mode
on an Applied Biosystems Voyager 4800 + MALDI TOF/TOF mass
spectrometer. Matrix ions were suppressed by setting the low
mass gate at 850 Da. To obtain optimal signal-to-noise ratios laser
power was adjusted on one sample and then maintained constant
for the others on the same sample plate. Each spectrum consisted
of ten to twenty subspectra with 50 shots each. Data were ana-
lyzed with Data Explorer 4.3 software (ABSciex). For quantiﬁcation,
the relative peak intensities for the different adducts ([M+H]+,
[M+Na]+ and [M+K]+) of each peptide were summed after the mass
spectra had been base-line corrected and de-isotoped; subse-
quently the ratios of the resulting relative peak intensities of the
ions of interest (AKH/AKH⁄, AKH-Gly/AKH⁄, MS/MS⁄, MS-Gly/MS⁄,
etc.) were calculated.
Fig. 2. The top panel shows the mass proﬁle of a retrocerebral complex from a control ﬂy (;;UAS-ATP7-RNAi/+). The characteristic AKH adducts [M+Na]+ and [M+K]+ are as
prominently present as are the same adducts of the stable isotope-labeled AKH standard (AKH⁄). The bottom panel shows the mass proﬁle of a retrocerebral complex from a
ﬂy in which ATP7 was inhibited (UAS-Dcr2/y;AKH-gal4/+;UAS-ATP7-RNAi/+). Here there are no AKH adduct ions, even though the AKH⁄ standard is easily detected; instead
there are Na+ and K+ adduct ions for the Gly-extended AKH.
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The hypotheses tested were that the combination of the three
transgenes – neuropeptide-gal4, UAS-ATP7-RNAi and UAS-Dicer2
– would lead to larger courtship and wing extension indexes, smal-
ler quantities of amidated neuropeptides and increased quantities
of Gly-extended neuropeptides. As the data were not normally dis-
tributed, we used the Wilcoxon rank-sum test to establish statisti-
cal signiﬁcance. Flies having a copy each of the neuropeptide-gal4
and UAS-Dicer2 transgenes were pooled with the data from ﬂies
having a single copy of the UAS-ATP7-RNAi transgene and com-
pared with ﬂies carrying all three transgenes.
3. Results and discussion
To test whether ATP7 is expressed in peptidergic cells, we per-
formed double immuno-stainings for several types of peptidergic
cells. In ATP7-gal4/UAS-LacZ ﬂies, LacZ immunoreactivity co-
localized with immunoreactivity to myosuppressin, corazonin,
SIFamide, capa, leucokinin, AKH and sNPF (Fig. 1). Although we
have not systematically tested every single C-terminally amidated
Drosophila neuropeptide for neuronal colocalisation of ATP7,
those that we did test were found to co-localize. However, not
all investigated peptidergic cells were equally clearly expressing
gal4 under the control of the ATP7 promotor. For example, in
some ﬂies not all of the relatively small corazonin interneurons
in the abdominal neuromeres were labeled; such individual vari-
ability was common for smaller neurons, but occasionally also
observed for larger cells. Such differences might be due to tempo-
ral patterns of expression, problems in detecting very low levels
of expression in small neurons, or because the expression of the
transgene does not entirely reﬂect expression of ATP7 itself. Nev-
ertheless, not all ATP7 expressing neurons are peptidergic, as cop-
per is also an essential cofactor for dopamine b-monooxygenase
[25] and ATP7 is thus likely also expressed in aminergic neurons
such as those producing octopamine.
Our results suggest a frequent colocalisation of ATP7 and neuro-
peptides. Since PHM depends on copper, we hypothesised that the
expression of ATP7 is needed for biological activity of PHM and
that in its absence, neuropeptides might be no longer become
C-terminally amidated. We observed that a large number of the
ATP7 expressing neurons were also immunoreactive withantiserum to Drosophila PHM [12], but we were unable to demon-
strate that all PHM neurons express ATP7 (data not shown). We do
not know whether this is caused by weak ATP7-gal4-driven repor-
ter expression, or whether some PHM neurons do not express
ATP7. There are also several neurons that express ATP7 but are
not recognized by the PHM antiserum. Some of these may well
be octopaminergic based on their location. Typically, antisera to
C-terminally amidated neuropeptides recognize the C-terminal
amide, and do not or only weakly recognize the intermediate neu-
ropeptide products, such as those which have C-terminal Gly or
Gly-Lys-Arg extensions. Our ﬁrst attempts were thus directed at
differences in immunoreactivity detectable with our various anti-
sera. We compared ﬂies with wild-type levels of ATP7 expression
with those in which ATP7 expression had been suppressed via
RNAi (see below). In a few preparations the staining intensity ap-
peared to be reduced in ﬂies expressing RNAi in myosuppressin
neurons, but not in all specimens and only when larvae were
grown on low copper food.
To conﬁrm that the expression of ATP7 RNAi inhibits PHM activ-
ity, we used mass spectrometry to analyze whether downregula-
tion of ATP7 by RNAi inhibited the C-terminal amidation of
neuropeptides. We thus expressed ATP7 RNAi in neuroendocrine
cells and/or neurons that express either adipokinetic hormone
(AKH), corazonin (Crz), myosupressin (MS) or SIFamide. In order
to maximize the effects of the ATP7 RNAi, a UAS-Dicer 2 transgene
was also added and ﬂies were raised on a low copper diet.
In UAS-Dcr2/+;AKH-gal4/+;UAS-ATP-RNAi/+ ﬂies, amidated
AKH was virtually absent and instead large quantities of AKH con-
taining a C-terminal Gly residue were observed. Gly-extended AKH
was found neither in UAS-Dcr2/+;AKH-gal4/+ nor in;;UAS-ATP-
RNAi/+ ﬂies, which contained normal quantities of AKH (Figs. 2
and 3). Similar results were obtained in the case of corazonin. In
UAS-Dcr2/+;Crzn-gal4/+;UAS-ATP-RNAi/+ ﬂies amidated corazonin
was only found in 2 out of 28 ﬂies and large quantities of Gly-ex-
tended corazonin were found in all but one of them. In contrast,
amidated corazonin was found in all UAS-Dcr2/+;corazonin-gal4/
+ and;;UAS-ATP-RNAi/+ ﬂies, and Gly-extended corazonins was
rarely present in these ﬂies (Fig. 3). The decrease in mature peptide
and the increase in Gly-extended neuropeptides are statistically
highly signiﬁcant (all P’s < 0.0001) for both AKH and corazonin.
To exclude the possibility that the observed effects are due to
off-target gene regulation by RNAi, we repeated these experiments
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part of the ATP7 gene, and found the same results (Fig. S2).
For both myosuppressin and SIFamide, the decrease in the
quantities of mature peptides was much less dramatic, and Gly-
extended neuropeptides were only found in a fraction of the testedFig. 3. Plots showing the relative concentration (measured as ratio relative to the stable
on the X-axis and its C-terminally extended Gly analog, the PHM substrate, on the Y-axis.
with a single outlier in b1 signiﬁcant quantities of Gly-extended neuropeptides are only
the speciﬁc cell type. The effects are very pronounced in the AKH and corazonin cells, but
+;AKH-gal4/+, a2:;;UAS-ATP7-RNAi/+, a3: UAS-Dcr2/+;AKH-gal4/+;UAS-ATP7-RNAi/+, b1
ATP7-RNAi/+, c1: UAS-Dcr2/+;MS-gal4/+, c2:;;UAS-ATP7-RNAi/+, c3: UAS-Dcr2/+;MS-gal
UAS-Dcr2/+;UAS-SIFa-gal4/+;UAS-ATP7-RNAi/+.ﬂies (Fig. 3). The difference in Gly-extended neuropeptides be-
tween control and experimental ﬂies barely reached signiﬁcance
for SIFamide (P < 0.05), and was not statistically different from con-
trols for myosuppressin. Still, in some experimental ﬂies, but not in
controls, large amounts of SIF-Gly were found, showing that theisotopically labeled AKH⁄ or myosuppressin⁄ standards) of mature amidated peptide
a1–a3, AKH, b1–b3, corazonin, c1–c3, myosuppressin and d1–d3 SIFamide. Note that
found in a3, b3, c3 and d3, i.e., in those ﬂies in which ATP7 was inhibited by RNAi in
much less so in the myosuppressin and SIFamide neurons. Genotypes: a1: UAS-Dcr2/
: UAS-Dcr2/+;Crzn-gal4/+, b2:;;UAS-ATP7-RNAi/+, b3: UAS-Dcr2/+;Crzn-gal4/+;UAS-
4/+;UAS-ATP7-RNAi/+, d1: UAS-Dcr2/+;UAS-SIFa-gal4/+, d2:;;UAS-ATP7-RNAi/+, d3:
Fig. 4. Courtship and wing extension indices of males toward males. The courting
males have the following genotypes: 1: UAS-Dcr2/y;SIFa-gal4/+, 2:;;UAS-ATP7-
RNAi/+ and 3: UAS-Dcr2/y;SIFa-gal4/+;UAS-ATP7-RNAi/+; ﬂies were raised on
normal ﬂy food (top panels) or on ﬂy food containing a copper chelator (bottom
pannels). Note that some, but not all, males of the UAS-Dcr2/y;SIFa-gal4/+;UAS-
ATP7-RNAi/+ genotype show male–male courtship behavior, but only when raised
on low copper food. Courtship and wing extension indices of the UAS-Dcr2/y;SIFa-
gal4/+;UAS-ATP7-RNAi/+ under low copper conditions are signiﬁcantly different
from those of the other ﬂies (P < 0.001; P < 0.02).
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which had signiﬁcant quantities of SIF-Gly still produced some
SIFamide, indicating that the effects of ATP7 RNAi in the SIFamide
neurons were not as pronounced as in AKH- or corazonin-
expressing cells.
Elimination of the SIFamide neurons by genetic ablation or sup-
pression of SIFamide synthesis by RNAi induces male-male court-
ship behavior in Drosophila [17]. We thus anticipated that if the
expression of ATP7 RNAi by the SIFamide neurons were able to sig-
niﬁcantly reduce the amounts of SIFamide produced by these neu-
rons, it might induce male–male courtship behavior. UAS-Dcr2/
y;SIFamide-gal4/+;UAS-ARNi-ATP7/+ ﬂies propagated on normal
ﬂy food showed no male-male courtship behavior, but when the
same experiment was repeated with ﬂies raised on food with a
copper chelator male–male courtship behavior was observed
(Fig. 4). However, although both the courtship and the wing exten-
sion indices were statistically signiﬁcantly higher in ﬂies in which
ATP7 expression was suppressed by RNAi (P < 0.001 and P < 0.02,
respectively), male–male courtship behavior only occurred in a
subset of males, and with a courtship intensity clearly less pro-
nounced than in males either lacking SIFamide neurons or in which
expression of the SIFamide gene was silenced by RNAi [17]. The
fractions of male ﬂies showing male–male sexual behavior was
similar to the fraction of ﬂies showing a perturbed processing of
SIFamide, and these data are thus concordant.
ATP7 RNAi is unlikely to be 100% efﬁcient in suppressing the
expression of ATP7 and in the presence of high copper concentra-
tions small amounts of ATP7 are likely sufﬁcient to insure func-
tional PHM in peptidergic neurons. This is similar to Menkes
patients, who have mutant ATP7A transporters retaining residual
copper transport activity. In such patients disease can be avoided
by subcutaneous injection of copper complexes, showing that in-
creased copper concentration can compensate a faulty ATP7A
transporter [3]. It is therefore not surprising that the use of a cop-
per chelator to decrease copper concentration makes it easier to
demonstrate the effects of a diminished ATP7 expression in Dro-
sophila peptidergic neurons.
Peptidergic neurons release peptides by exocytosis, and when
this occurs PHM, which is bound to the membrane of the secretory
granule, is exposed to the extracellular medium until it is reinter-
nalized by endocytosis. As the copper ion is not tightly bound [26],
this is an occasion where it may be readily lost from the enzyme.
Rapid turnover rates of peptides might thus be associated with
concomitantly high turnover rates of copper, but whereas the cel-
lular machinery can handle high peptide turnover rates, in the ab-
sence of normal quantities of ATP7 it might not be able to replenish
the copper sufﬁciently fast. Thus diminished ATP7 expression
might have stronger effects in actively secreting cells and this
might explain why the effects of ATP7 RNAi were more robust on
the AKH and corazonin neuroendocrine cells as compared to the
myosuppressin and SIFamide cells. Furthermore, in actively secret-
ing cells with a high rate of peptide synthesis, the production of
gal4 is likely to be higher than in quiescent cells, since peptide
synthesis is activated by the same promotor that drives gal4-
expression. Thus in actively secreting cells the expression of
ATP7 RNAi is expected to be increased and this may provide an
additional explanation as to why the effects of ATP7 RNAi may
be more pronounced in actively secreting cells. Although it could
also be argued that the gal4 drivers used for the AKH and corazonin
cells are stronger than those used in the SIFamide and myosup-
pressin neurons, we feel this is unlikely, as apoptosis induced by
UAS-reaper in the various neurons follows similar time scales
(unpubl. data).
In the case of a genetic defect in a widely expressed protein like
ATP7A it is not easy to pinpoint where exactly diminished enzyme
activity causes pathological problems. Indeed, the same genetic de-fects can lead to different symptoms. It has previously been shown
that in mottled brindled mice, a murine model for Menkes disease,
neuropeptide amidation is reduced, implying a reduction in PHM
activity [26,27]. However, technical difﬁculties made it impossible
to demonstrate differences in PHM activity [27]. By diminishing
expression of ATP7 speciﬁcally in four different peptidergic cell
types using Drosophila genetics, we were now able to show that
in all four cell types neuropeptide amidation is perturbed, but that
the degree is different from one cell type to another, even though
the direct effect, i.e., lack of sufﬁcient copper for PHM, is likely
the same. Even in genetically identical individuals we did not al-
ways see the same phenotypes, as in the case of SIFamide andmyo-
suppressin. Similar differences in Menkes patients could explain
why symptoms vary from patient to patient.Acknowledgements
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